UPDATED Aug 24, 2025
Discover large cap Global companies from around the world. These companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CTRA | Rp1,010.00 | -2.4% | -21.7% | Rp18.7t | Rp1,390.00 | PE8x | E3.1% | 2.4% | Real Estate Management and Development | ||
688526 | CN¥17.63 | 2.3% | 48.9% | CN¥8.2b | CN¥21.75 | PE20.3x | E12.6% | 2.4% | Pharmaceuticals & Biotech | ||
BASS | €58.40 | -0.7% | 36.4% | €974.0m | €76.00 | PE10.7x | n/a | 1.7% | Real Estate Management and Development | ||
OU8 | S$1.74 | 0.6% | 148.6% | S$1.5b | S$1.77 | PE4.9x | E-32.1% | 2.3% | Real Estate Management and Development | ||
300368 | CN¥15.46 | -7.4% | 520.9% | CN¥8.2b | n/a | PS58.6x | n/a | 0% | Tech | ||
VLTSA | €7.44 | 1.8% | -10.9% | €973.8m | €11.37 | PS1.8x | E84.0% | n/a | Utilities | ||
MIPS | SEK 409.20 | 2.7% | -19.4% | SEK 10.8b | SEK 575.00 | PE77.4x | E41.9% | 1.6% | Consumer Durables | ||
500335 | ₹1,293.50 | 1.8% | -2.5% | ₹99.6b | ₹1,595.08 | PE26.1x | E25.3% | 0.8% | Materials | ||
LENZ | US$40.00 | 5.7% | 77.8% | US$1.1b | US$50.88 | PS228.2x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
OSWALPUMPS | ₹873.80 | 10.0% | n/a | ₹99.6b | n/a | PE32.7x | n/a | n/a | Capital Goods | ||
603985 | CN¥18.54 | 3.1% | 98.3% | CN¥8.2b | n/a | PS3.9x | n/a | 0% | Capital Goods | ||
9948 | JP¥3,105.00 | 1.6% | 21.1% | JP¥167.6b | JP¥3,100.00 | PE15x | E2.9% | 2.4% | Consumer Retailing | ||
IRSA | AR$2,005.00 | -1.7% | 57.3% | AR$1.5t | n/a | PE8.4x | E7.9% | 10.1% | Real Estate Management and Development | ||
600975 | CN¥6.47 | 2.2% | 17.9% | CN¥8.2b | CN¥8.42 | PE26.1x | E1.7% | 0% | Food, Beverage & Tobacco | ||
2290 | CN¥32.89 | 9.3% | 181.8% | CN¥8.2b | n/a | PE61.1x | E31.5% | 0% | Materials | ||
SNL | AU$40.39 | 8.5% | 50.7% | AU$1.8b | AU$35.27 | PE46.5x | E14.8% | 1.6% | Retail | ||
SPI | ฿43.00 | 1.8% | -3.7% | ฿36.9b | n/a | PE12.5x | n/a | 1.4% | Real Estate Management and Development | ||
777 | CN¥21.28 | 1.1% | 52.1% | CN¥8.2b | CN¥17.85 | PE35.1x | E19.1% | 0.9% | Capital Goods | ||
600708 | CN¥3.66 | 1.1% | 108.0% | CN¥8.2b | n/a | PS1.7x | n/a | 0% | Real Estate Management and Development | ||
AREIT | €555.00 | 0.9% | 23.3% | €971.4m | n/a | PB1.4x | n/a | n/a | Real Estate Management and Development | ||
534 | CN¥16.90 | 1.4% | 83.5% | CN¥8.2b | CN¥24.00 | PE40.9x | E28.9% | 0.3% | Pharmaceuticals & Biotech | ||
600169 | CN¥2.44 | 0.8% | 34.8% | CN¥8.2b | n/a | PE41.5x | n/a | 0% | Capital Goods | ||
CIMSA | ₺49.34 | 3.1% | 47.3% | ₺46.7b | ₺67.40 | PE32.5x | n/a | 1.3% | Materials | ||
TOPGLOV | RM 0.60 | -0.8% | -38.8% | RM 4.8b | n/a | PE75.3x | E56.3% | 0% | Healthcare |